INTEGRAMED AMERICA INC
SC 13G/A, 1998-02-18
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: VMARK SOFTWARE INC, SC 13D, 1998-02-18
Next: NINE WEST GROUP INC /DE, SC 13G, 1998-02-18



United States
Securities and Exchange Commission
Washington, D.C.  20549


SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 3)


Name of Issuer:                              IntegraMed America, Inc.
Title of Class of Securities:             Common Stock
CUSIP Number:                              45810N104





CUSIP No. 45810N104                                           Page 2 of 4 Pages

1. Name of Reporting Person                Alphi Investment Management Company
                                                            IRS No. 36-3588013

2. Check the appropriate box if a member of a group     (a) [ ]      (b) [ ]

3. SEC Use Only

4. Citizenship or Place of Organization                       Illinois

5. Sole Voting Power                                     1,011,000

6. Shared Voting Power                                               0

7. Sole Dispositive Power                               1,011,000

8. Shared Dispositive Power                                        0

9. Aggregate Amount Beneficially Owned by Each Reporting Person      
          1,011,000

10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares     [ ]

11. Percent of Class Represented by Amount in Row 9        5.9%

12. Type of Reporting Person                       CO









CUSIP No. 45810N104                                  Page 3 of 4 Pages

Item 1(a).  Name of Issuer

This Amendment No. 3 to the Schedule 13G relates to the Shares of Common
Stock of IntegraMed America, Inc. (the "Shares" and the "Company" 
respectively).

Item 1(b).  Address of Issuer's Principal Executive Offices

     The executive offices of the Company are located at One 
Manhattanville Road, Purchase, NY  10577.

Item 2(a).  Name of Person Filing

     This Amendment No. 3 to the Schedule 13G is being filed on behalf 
of Alphi Investment Management Company ("AIMCO"), an Illinois corporation.

Item 2(b).  Address of Principal Business Office

     The principal business offices of AIMCO are located at 155 Pfingsten 
Road, Suite 360, Deerfield, IL  60015.

Item 2(c).  Citizenship

     U.S.A.

Item 2(d).  Title of Class of Securities

     Common Stock

Item 2(e).  CUSIP Number

      45810N104

Item 3.  Type of Person

Corporation, passive investor

Item 4.  Ownership
     (a)   Amount Beneficially Owned:   1,011,000
     (b)   Percent of Class:                 5.9%
     (c)   Number of shares as to which person has:
       (1)  sole power to vote or to direct the vote:              1,011,000
       (2)  shared power to vote or to direct the vote:                    0
       (3)  sole power to dispose or to direct the disposition of: 1,011,000
       (4)  shared power to dispose or to direct the disposition of:       0

Item 5.  Ownership of Five Percent or less of a Class:
     Not applicable.

Item 6.  Ownership of More than Five Percent on Behalf of Another Person
     Alphi Fund L.P. ("Alphi"), a Delaware limited partnership is  the 
beneficial owner of 1,011,000 Common Shares, which is 5.9% of the 
17,198,616 Shares of the Company deemed to be outstanding as of 
December 31, 1997.  AIMCO, in its capacity as general partner of 
Alphi, has the sole power to vote and sole power to dispose of 
1,011,000 Common Shares owned by Alphi.  Individual limited partners 
of Alphi (but not the principals of AIMCO) may own Shares which are 
not included in the aggregate number of Shares reported in Item 4 above.

Item 7.	Identification and Classification of the Subsidiary Which 
Acquired the Security Being Reported on By the Parent Holding Company	
     Not applicable.

Item 8.  Identification and Classification of Members of the Group	
     Not applicable.

Item 9.  Notice of Dissolution of Group		
     Not applicable.

Item 10.  Certification

By signing below, I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of 
business and were not acquired for the purpose of and do not have the 
effect of changing or influencing the control of the issuer of such 
securities and were not acquired in connection with or as a participant 
in any transaction having such purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I 
certify that the information set forth in this statement is true, complete
and correct.

February 17, 1998
Date

/Philip R. Smith/
Signature

Philip R. Smith/Secretary
Name/Title



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission